Hiroyuki Aburatani
Inventor
Stats
- 23 US patents issued
- 60 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 23 US Patents Issued
- 60 US Applications Filed
- 487 Total Citation Count
- Aug 19, 2021 Most Recent Filing
- Dec 18, 2001 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
PERSEUS PROTEOMICS INC. | 1
2 6 1 4 1 2 6 2 3 4 | 2003
2004 2005 2006 2007 2008 2009 2010 2011 2013 2014 |
TOUDAI TLO, LTD. | 1
| 2005
|
SYSMEX CORPORATION | 2
2 1 | 2011
2014 2015 |
ABURATANI, HIROYUKI | 2
1 2 | 2009
2010 2014 |
ABURATANI, HIROYKI | 1
| 2004
|
HAPLOPHARMA INC. | 2
| 2005
|
HIROYUKI ABURANTAI | 1
| 2004
|
ABURANTAI, Hiroyuki | 1
1 1 | 2006
2008 2010 |
HIROYKI ABURATANI | 1
| 2004
|
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY | 1
1 1 | 2001
2002 2005 |
NGK INSULATORS, LTD. | 1
| 2003
|
CHUGAI SEIYAKU KABUSHIKI KAISHA | 1
3 3 2 6 1 8 6 2 1 3 2 3 | 2003
2004 2005 2006 2007 2008 2009 2010 2011 2012 2014 2015 2016 |
FORERUNNER PHARMA RESEARCH CO., LTD. | 1
| 2007
|
THE UNIVERSITY OF TOKYO | 4
8 5 6 6 1 4 3 4 2 | 2005
2007 2009 2010 2011 2012 2013 2014 2015 2016 |
AJINOMOTO CO., INC. | 1
| 2002
|
TOHOKU UNIVERSITY | 1
| 2015
|
Inventor Addresses
Address | Duration |
---|---|
3-30-16, Kichijoji Minami-cho | Oct 12, 10 - Oct 12, 10 |
Bunkyo-ku, JP | Jul 12, 12 - Sep 07, 21 |
Musashino, JP | Apr 06, 10 - Sep 25, 12 |
Musashino-shi, JP | May 18, 06 - Nov 24, 11 |
Tokyo, JP | Jul 31, 03 - Dec 09, 21 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 2 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 27 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 12 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2021/0380,715 | 2021 | ANTI-DLL3 ANTIBODY | 6 |
11111311 | 2021 | Anti-DLL3 antibody | 4 |
10696743 | 2020 | Diagnosis and treatment of cancer using anti-desmoglein-3 antibodies | 0 |
2020/0181,248 | 2020 | ANTIBODY AGAINST SECRETED N-TERMINAL PEPTIDE OF GPC3 PRESENT IN BLOOD OR C-TERMINAL PEPTIDE OF GPC3 | 0 |
2020/0157,231 | 2020 | DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-LGR7 ANTIBODY | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.